ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a supplement stop hair loss? new study investigates
Disease control CompletedThis study tested whether a dietary supplement (capsules and drink) could reduce hair loss in 240 adults with androgenetic alopecia or chronic telogen effluvium. Participants took the supplement or a placebo daily for 6 months. Researchers measured hair density and asked about pr…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: NA • Sponsor: Lacer S.A. • Aim: Disease control
Last updated Jun 17, 2026 06:58 UTC
-
New hair loss drug shows promise in early trial
Disease control CompletedThis study tested a new medication called CG2001 for male pattern baldness in Chinese men aged 18 to 65. The goal was to see if it helps regrow hair and is safe to use. The trial involved 110 participants and measured changes in hair count after 24 weeks.
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE2 • Sponsor: Beijing Dayspring Pharmaceutical Technology Co., Ltd • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
PRP shows promise for thinning hair in small study
Disease control CompletedThis study tested whether platelet-rich plasma (PRP) can treat androgenetic alopecia, a common form of hair loss. Thirty adults with moderate to severe hair loss received PRP injections. Researchers measured hair amount and follicle density using a dermoscope and MRI to see if th…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Hair loss hope? study tests latanoprost acid in women
Symptom relief CompletedThis study tested whether applying a cosmetic ingredient called latanoprost acid to the scalp could improve hair growth in women aged 18-60 with female pattern hair loss or chronic telogen effluvium. Twenty-nine women used one of three strengths of the product daily for six month…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC